Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B.
about
The promise of neuroprotective agents in Parkinson's diseaseMonoamine oxidase enzymes and oxidative stress in the rat optic nerve: age-related changesThe diverse functions of GAPDH: views from different subcellular compartmentsAdjuvant potential of selegiline in attenuating organ dysfunction in septic rats with peritonitisGOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylationDopamine neuron stimulating actions of a GDNF propeptideGlyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan.Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson's DiseaseProtection against Parkinson's disease progression: clinical experience.The role of rasagiline in the treatment of Parkinson's disease.Oxidative stress as a mediator of cardiovascular disease.Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors.Safinamide for the treatment of Parkinson's disease.Mechanisms of cardiac radiation injury and potential preventive approaches.Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells.Interaction of Tetracapsuloides bryosalmonae, the causative agent of proliferative kidney disease, with host proteins in the kidney of Salmo trutta.The effects of endogenous non-peptide molecule isatin and hydrogen peroxide on proteomic profiling of rat brain amyloid-β binding proteins: relevance to Alzheimer's disease?Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?Biological targets for isatin and its analogues: Implications for therapy.Potential markers and metabolic processes involved in the mechanism of radiation-induced heart injury.Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and dna damage in a diabetic rat model.Isatin, an endogenous nonpeptide biofactor: A review of its molecular targets, mechanisms of actions, and their biomedical implications.
P2860
Q21129436-BDB45F92-4E6C-4F47-85BE-E30A04541859Q24600123-661A27A2-26A6-453A-A44B-8CC6068AD58CQ28291106-60341235-9C25-430F-B6AF-09E45351AD02Q28543423-4265417C-48E7-4D1C-8C83-2390C8C3A76AQ28570143-F91AFCA1-38F2-4FC3-AFC7-57D677AED35FQ28748465-BE6E73F9-FE29-43C6-B8AC-9855B21B3DC3Q33821908-20DCB3F2-5098-4F28-BD7C-20026A4D54EFQ36421954-934DF5E4-B4C4-4B1D-87BD-01823B2F5CE9Q36499640-4B463554-1C2D-4671-A14D-C513ADEB355DQ36512635-85C4AD08-CEC0-4928-9FD7-1255170CF6CAQ37131239-FE2C5535-0194-4C5A-A864-4AD473FCAD16Q37762167-F3CCDC42-2262-45AB-BA3A-80EE93F32416Q37780644-893D036F-1006-438F-A51D-6320A62EE3CEQ38067297-7694BBCF-BCAA-48CA-991E-4D0366A3B5C0Q38258514-936301CA-C130-41B6-A500-95FD62A47A19Q38510734-69E751D9-276C-4AB8-A4A7-0AF40418936FQ38545359-23AC9F17-7A09-4605-B433-29838A7EA8AAQ40003995-BD377626-FDC5-475D-BF98-644B36F7E935Q40017931-22113B54-F95A-46CA-B4E0-9ACDA050F531Q41635913-8247C604-484F-4EA6-BEED-D6372DF3A710Q42399167-9EB5E172-7FCE-4EE3-A669-038DC5B4993AQ43078223-C2947A98-13A7-4187-BE3E-D1D3F71BA45DQ45064258-43DD2F1D-E2E0-4B5D-B0F1-1E7B6C9BDA40Q46879105-0761D7AE-DD56-4499-8056-3A3335307551Q47863261-E104D3CE-FCE3-4E68-AA2A-993BF2CFFAE2
P2860
Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Neuroprotection by deprenyl an ...... ther than monoamine oxidase B.
@ast
Neuroprotection by deprenyl an ...... ther than monoamine oxidase B.
@en
type
label
Neuroprotection by deprenyl an ...... ther than monoamine oxidase B.
@ast
Neuroprotection by deprenyl an ...... ther than monoamine oxidase B.
@en
prefLabel
Neuroprotection by deprenyl an ...... ther than monoamine oxidase B.
@ast
Neuroprotection by deprenyl an ...... ther than monoamine oxidase B.
@en
P2093
P1476
Neuroprotection by deprenyl an ...... ther than monoamine oxidase B.
@en
P2093
R Chalmers-Redman
P2888
P304
P356
10.1007/S00702-002-0827-Z
P577
2003-05-01T00:00:00Z